Cancer News and Research

Latest Cancer News and Research

NiTi Surgical Solutions to showcase its investigational bowel anastomosis device at the 95th ACS Congress

NiTi™ Surgical Solutions, an innovative surgical device company, today announced that it will showcase its new, investigational bowel anastomosis device this week at the American College of Surgeons (ACS) 95th Annual Clinical Congress in Chicago, Illinois. The device, which will be marketed as BowelRing™, represents the company’s next advancement in its innovative BioDynamix™ Anastomosis Technology platform.

12 Oct 2009

American Airlines Admirals Club's initiative to support breast cancer awareness

American Airlines Admirals Club® lounges are thinking pink throughout October, National Breast Cancer Awareness Month, by hosting rosy celebrations at the 44 club locations worldwide with specialty menu items in support of breast cancer awareness.

12 Oct 2009

WellPoint honored for its "Journey Forward" initiative

WellPoint, Inc. was recognized today as a 2009 BlueWorks® award winner. BlueWorks is a unique partnership between the Blue Cross and Blue Shield Association (BCBSA) and the Harvard Medical School Department of Health Care Policy that honors health care innovation that improves the quality and value of health care for consumers.

12 Oct 2009

Novadaq Technologies commercializes patented visualization technology

Novadaq Technologies Inc., headquartered in Mississauga, Ontario, Canada, has commercialized SPY imaging, a patented visualization technology that enables surgeons to monitor circulation and tissue perfusion intraoperatively, facilitating surgical mapping and revisions during major procedures.

12 Oct 2009

ImaginAb and BZL Biologics conclude sublicense agreement for antibody technology

ImaginAb, Inc. and BZL Biologics, LLC have concluded a sublicense of BZL's PSMA/huJ591 antibody technology for the field of diagnostic imaging for PET and SPECT. "ImaginAb is pleased to have completed this [sub]licensing agreement with BZL as we believe that huJ591 will form the basis of an excellent clinical product for the diagnosis and management of prostate cancer.

12 Oct 2009

Researchers identify genes that play a role in the development of endometrial cancer

Researchers at the University of Gothenburg, Sweden, have identified two genes believed to play a role in the development of endometrial cancer. These results may eventually lead to better diagnosis and treatment of this increasingly common form of cancer.

12 Oct 2009

GetWell Town Interactive Patient Care system for children's hospitals

GetWellNetwork, Inc., today introduced GetWell Town(TM), the industry's first and only Interactive Patient Care system designed specifically for pediatric patients.

12 Oct 2009

Female lawmakers shape health care with their own stories

CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."

12 Oct 2009

Sophora installs ChromoCure's cancer detection systems

ChromoCure, Inc. today announced its has executed a Joint Venture Agreement with Sophora Diagnostic Lab, Inc., a profitable New York based cancer pathology lab ("Sophora").

12 Oct 2009

QRxPharma signs contractual agreement with Patheon

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).

12 Oct 2009

Imprivata conducts joint webinar with Carefx on healthcare management

Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it will be conducting a joint webinar with Carefx, a leading provider of interoperable workflow solutions.

12 Oct 2009

Grid technology enables accurate healthcare data exchange between physician EHRs and hospitals

Medicity, Inc., leading provider of health information exchange (HIE) technology, announced today that Craig Bakken, CEO of Rocky Mountain Gastroenterology Associates (RMGA), will co-present with Medicity Vice President Doug Arent at the Medical Group Management Association (MGMA) annual conference on Monday, October 12th, from 3:15-4:30 p.m. Mountain Time at the Colorado Convention Center.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O’Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.

12 Oct 2009

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields.

12 Oct 2009

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).

12 Oct 2009

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

OptumHealth Inc. has teamed with The Children’s Hospital of Philadelphia (CHOP) to present a two-day educational conference focused on clinical advancements in fetal diagnosis and treatment, neonatal care and pediatric care. The gathering runs through today, and is part of OptumHealth’s Network Spotlight Conferences program.

12 Oct 2009

University of Leicester biochemist to present research on the functions of stem cells in the intestine

A University of Leicester Biochemist will present her research on the functions of stem cells in the intestine at a free public lecture.

12 Oct 2009

Wake Forest University School of Medicine honours researchers

Wake Forest University School of Medicine honored eight of its researchers with awards for excellence at the 13th Annual Research Awards Day Oct. 1.

12 Oct 2009

Santarus and Norgine enter into a licensing agreement for ZEGERID products

Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.

12 Oct 2009

Cancer News and Research

Latest Cancer News and Research

NiTi Surgical Solutions to showcase its investigational bowel anastomosis device at the 95th ACS Congress

American Airlines Admirals Club's initiative to support breast cancer awareness

WellPoint honored for its "Journey Forward" initiative

Novadaq Technologies commercializes patented visualization technology

ImaginAb and BZL Biologics conclude sublicense agreement for antibody technology

Researchers identify genes that play a role in the development of endometrial cancer

GetWell Town Interactive Patient Care system for children's hospitals

Female lawmakers shape health care with their own stories

Sophora installs ChromoCure's cancer detection systems

QRxPharma signs contractual agreement with Patheon

Imprivata conducts joint webinar with Carefx on healthcare management

Grid technology enables accurate healthcare data exchange between physician EHRs and hospitals

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

University of Leicester biochemist to present research on the functions of stem cells in the intestine

Wake Forest University School of Medicine honours researchers

Santarus and Norgine enter into a licensing agreement for ZEGERID products

Understanding the DNA Damage Response in Innate Immunity eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in